Expert Interview
Digging into the launch of Springworks Therapeutics' Ogsiveo (nirogacestat) in adult patients with progressive desmoid tumors
Ticker(s): SWTXInstitution: Mayo Clinic
- Professor of Oncology,, Chair of the Division of Community Oncology for the Department of Oncology and is Chair of the Mayo Clinic Health System Cancer Committee.
- Treats ~25 desmoid and ~10 TGCT patients.
- Research interests include the management of patients with bone and soft tissue sarcomas, as well as head and neck cancers.employing a multidisciplinary approach with surgeons and radiation oncologists.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
